SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
KIER ISAAC

(Last) (First) (Middle)
1775 BROADWAY, SUITE 604

(Street)
NEW YORK NY 10019

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Hana Biosciences Inc [ HNAB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/16/2007
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 78,748 D
Common Stock 151,528 I By Kier Family LP(1)
Common Stock 7,000 I By Isaac Kier Charitable Remainder Trust
Common Stock 11/16/2007 S 500 D $1.46 119,842 I By JIJ Investments(2)
Common Stock 11/16/2007 S 7,838 D $1.45 112,004 I By JIJ Investments(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options $1.684 (3) 02/01/2014 Common Stock 28,201 28,201 D
Stock Options $1.33 (4) 04/11/2015 Common Stock 20,000 20,000 D
Stock Options $1.65 (4) 07/14/2015 Common Stock 20,000 20,000 D
Stock Options $4.75 11/10/2006 11/10/2015 Common Stock 40,000 40,000 D
Stock Options $6.82 12/12/2007 12/12/2016 Common Stock 50,000 50,000 D
Warrants $1.57 (5) 04/22/2010 Common Stock 5,859 5,859 D
Warrants $5.8 04/21/2006 10/21/2010 Common Stock 4,357 4,357 I By Kier Family LP(1)
Warrants $1.57 (5) 04/22/2010 Common Stock 23,437 23,437 I By JIJ Investments(2)
Explanation of Responses:
1. A limited partnership, of which the Reporting Person is a general partner.
2. A partnership, of which the Reporting Person is a partner.
3. 9,400 shares vest on each of 2/1/05 and 2/1/06 and 9,401 shares vest on 2/1/07.
4. 6,667 shares vest on each of 4/11/2006 and 4/11/2007; 6,666 shares vest on 4/11/2008.
5. Immediately exercisable.
/s/ Isaac Kier 11/20/2007
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.